The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcome of patients with germline DNA repair mutations: Results from a retrospective international study.
 
Joaquin Mateo
Travel, Accommodations, Expenses - AstraZeneca; Sanofi
 
Heather H. Cheng
Research Funding - Astellas Medivation; Inovio Pharmaceuticals; Janssen; Sanofi
 
Himisha Beltran
Consulting or Advisory Role - Bayer; Genzyme; GlaxoSmithKline; Janssen Oncology
Research Funding - Abbvie/Stemcentrx; Astellas Pharma (Inst); Janssen (Inst)
 
David Dolling
No Relationships to Disclose
 
Wen Xu
No Relationships to Disclose
 
Colin Pritchard
No Relationships to Disclose
 
Helen Mossop
No Relationships to Disclose
 
Pasquale Rescigno
No Relationships to Disclose
 
Raquel Perez-Lopez
No Relationships to Disclose
 
Verena Sailer
No Relationships to Disclose
 
Michael Paul Kolinsky
No Relationships to Disclose
 
Ada Balasopoulou
No Relationships to Disclose
 
Claudia Bertan
No Relationships to Disclose
 
Suzanne Carreira
No Relationships to Disclose
 
Heather Thorne
No Relationships to Disclose
 
Robert B. Montgomery
Research Funding - ESSA; Ferring; Janssen Oncology; Medivation/Astellas
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Mark A. Rubin
Research Funding - Janssen; Lilly
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; Roche/Genentech
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex